ARRY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Array BioPharma Inc's other long-term assets for the quarter that ended in Sep. 2014 was $4.78 Mil.
Array BioPharma Inc's quarterly other long-term assets declined from Mar. 2014 ($9.25 Mil) to Jun. 2014 ($9.22 Mil) and declined from Jun. 2014 ($9.22 Mil) to Sep. 2014 ($4.78 Mil).
Array BioPharma Inc's annual other long-term assets increased from Jun. 2012 ($-71.32 Mil) to Jun. 2013 ($4.63 Mil) and increased from Jun. 2013 ($4.63 Mil) to Jun. 2014 ($9.22 Mil).
Assets are presented on the balance sheet in order of their liquidity. If a company expects to sell or otherwise recognize the economic value of an asset within one year, the asset is generally classified as a current asset on the balance sheet. Cash on hand is a common current asset.
A long-term asset is an asset that a company expects to sell or otherwise recognize the economic value of after more than one year. Property, plant and equipment, and intangible assets are common long-term assets. Except those two items and current assets, the others we treated as "Other Long Term Assets".
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Array BioPharma Inc Annual Data
|Other Long-Term Assets||0.08||0.00||1.50||32.16||23.64||20.47||3.11||-71.32||4.63||9.22|
Array BioPharma Inc Quarterly Data
|Other Long-Term Assets||-71.32||2.86||-73.60||2.55||4.63||9.33||9.43||9.25||9.22||4.78|